MOTS-C mitochondrial-derived research peptide vial 40mg — RETA UK

MOTS-C

40mg
£80.00
Sale price  £80.00 Regular price 
Skip to product information
MOTS-C mitochondrial-derived research peptide vial 40mg — RETA UK

MOTS-C

★★★★ 4.7 · 200+ orders served

MOTS-C is a research-grade mitochondrial-derived peptide (MDP) consisting of 16 amino acids encoded within the mitochondrial 12S rRNA gene rather than nuclear DNA. This unique genomic origin redefined our understanding of mitochondria as active endocrine signalling organs. MOTS-C plays a critical role in metabolic homeostasis through activation of AMP-activated protein kinase (AMPK) and modulation of glucose and fatty acid metabolism, making it a reference compound for studying mitochondrial signalling in metabolic and longevity research.

Available in 40mg vials. Every batch is HPLC tested and independently verified to a minimum of 99% purity. Certificate of Analysis available on request.

Research applications include:

  • AMPK activation and cellular energy homeostasis pathway studies
  • Insulin sensitivity and glucose metabolism research
  • Fatty acid oxidation and mitochondrial function investigation
  • Mitochondrial-nuclear retrograde signalling pathway research
  • Longevity-associated cellular resilience and anti-ageing mechanism studies
  • Comparative research vs other mitochondrial-derived peptides

Product specifications:

  • Form: Lyophilised powder
  • Purity: ≥99% (HPLC verified)
  • Storage: −20°C, protected from light and moisture
  • Available size: 40mg
  • Origin: UK warehouse, same day dispatch
Size
Multibuy Discount Available
Buy 2 save 5% Buy 3 save 10% Buy 4 save 15% Buy 5+ save 20%
£80.00
Sale price  £80.00 Regular price 
✓ 99%+ Purity Guaranteed ✓ COA Available ✓ Same Day UK Dispatch ✓ Secure Checkout
For research purposes only. This product is not intended for human or veterinary use, consumption, or self-administration. Must be handled by qualified professionals in a suitable laboratory environment. Not evaluated by the MHRA or any regulatory authority for therapeutic use. Read full disclaimer →

You may also like